Viemed Healthcare, Inc. $VMD Shares Purchased by Trexquant Investment LP

Key Points

• Trexquant Investment LP increased its stake in Viemed Healthcare, Inc. (NASDAQ: VMD) by 68.9%, owning approximately 0.25% of the company, valued at $717,000.
• Other institutional investors significantly boosted their holdings in Viemed Healthcare, with GSA Capital Partners increasing their stake by 497.7%
• Director Nitin Kaushal sold 34,100 shares at an average price of $7.01, resulting in a 21.19% decrease in his ownership of the stock.

Trexquant Investment LP boosted its position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 68.9% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 98,531 shares of the company's stock after purchasing an additional 40,185 shares during the quarter. Trexquant Investment LP owned about 0.25% of Viemed Healthcare worth $717,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Wells Fargo & Company MN lifted its holdings in shares of Viemed Healthcare by 51.7% during the 4th quarter. Wells Fargo & Company MN now owns 16,024 shares of the company's stock valued at $129,000 after purchasing an additional 5,461 shares during the last quarter. Hsbc Holdings PLC purchased a new stake in shares of Viemed Healthcare during the 4th quarter valued at $108,000. Price T Rowe Associates Inc. MD lifted its holdings in shares of Viemed Healthcare by 18.1% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 13,005 shares of the company's stock valued at $105,000 after purchasing an additional 1,997 shares during the last quarter. Northern Trust Corp lifted its holdings in shares of Viemed Healthcare by 1.8% during the 4th quarter. Northern Trust Corp now owns 286,818 shares of the company's stock valued at $2,300,000 after purchasing an additional 5,090 shares during the last quarter. Finally, Ameriprise Financial Inc. acquired a new position in shares of Viemed Healthcare in the 4th quarter valued at $340,000. Institutional investors own 74.24% of the company's stock.

Viemed Healthcare Stock Performance

VMD stock traded down $0.16 during midday trading on Tuesday, reaching $6.71. The stock had a trading volume of 128,458 shares, compared to its average volume of 239,569. The stock has a market cap of $260.28 million, a PE ratio of 19.74 and a beta of 1.38. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.37 and a current ratio of 1.48. The firm has a fifty day simple moving average of $6.79 and a two-hundred day simple moving average of $6.92. Viemed Healthcare, Inc. has a 52-week low of $5.93 and a 52-week high of $9.81.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.08. The business had revenue of $63.06 million during the quarter, compared to analysts' expectations of $63.50 million. Viemed Healthcare had a return on equity of 10.38% and a net margin of 5.80%.

Insider Buying and Selling

In other Viemed Healthcare news, Director Nitin Kaushal sold 34,100 shares of the stock in a transaction that occurred on Friday, June 27th. The stock was sold at an average price of $7.01, for a total transaction of $239,041.00. Following the completion of the transaction, the director owned 126,843 shares of the company's stock, valued at $889,169.43. This represents a 21.19% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, President Michael Moore sold 50,090 shares of the firm's stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $7.33, for a total transaction of $367,159.70. Following the completion of the transaction, the president directly owned 126,343 shares in the company, valued at $926,094.19. This trade represents a 28.39% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 97,922 shares of company stock valued at $703,886. 20.00% of the stock is owned by company insiders.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.